Breaking news Moderna rises 4% on optimism about RSV jab Gennaio 18, 2023 Moderna Inc.’s stock rose above 4% on Wednesday, as investors drew optimism from the company’s announcement on the efficiency of the vaccine for respiratory syncytial virus or RSV. According …
